Page URL:

Newborns' stem cells lost in storage failure

9 April 2018
Appeared in BioNews 944

A storage failure at a private UK tissue bank may have resulted in the loss of valuable stem cell samples obtained from newborn babies.

Reports suggest staff were unable to process multiple umbilical cord blood samples due to a shortage of basic laboratory supplies following the financial collapse of Precious Cells International (PCI).

Umbilical cord blood is a rich source of stem cells collected at birth from tissue that would otherwise be discarded, offering a less controversial alternative to embryonic stem cells

These cells can be banked privately for personal or family use – as a safeguard in case of future illness – or donated to a public bank to benefit others. The stem cells can be used to treat a range of conditions including sickle cell anaemia and leukaemia.

PCI, based in Stockley Park near London, had partnerships with six NHS hospitals. They are working with the Human Tissue Authority (HTA) to establish the viability of the samples in question.

The HTA said. 'We have identified a small number of client samples that were not processed or stored. We are working with the administrators to ensure customers are advised appropriately and that banked samples continue to be preserved under suitable conditions.'

Speaking to The Sunday Times, Allan Marriot-Smith, the HTA's chief executive, said the body would take action if evidence of 'regulatory breaches or other offences' was found. 

In response to the current situation, PCI stated that it was 'with sadness that the company entered into administration'. 

Their lawyers continued: 'All samples remain safe and secure... and administrators are working with the regulatory bodies to ensure future access to the company's public stem cell bank is available for all hospitals.'

Precious Cells and Pharmacells to enter into administration
Human Tissue Authority |  29 March 2018
Probe launched over babies stem cell storage ‘failure’
The Sunday Times |  1 April 2018
20 May 2019 - by Dr Loredana Guglielmi 
The number of new parents paying to bank their baby's umbilical cord blood for future use in stem cell therapies or transplantation in case of illness has increased by 59 percent in the space of four years in the UK...
21 May 2018 - by Lone Hørlyck 
Crowdfunding campaigns to raise money for stem cell treatments tend to exaggerate potential benefits while understating potential risks of the interventions, suggests a new study...
30 April 2018 - by Shaoni Bhattacharya 
Scientists have unveiled a detailed roadmap of how an embryo forms from a single cell over 24 hours...
26 March 2018 - by Dr Zeynep Gurtin 
Last week, the Human Fertilisation and Embryology Authority released its much-anticipated report 'Fertility Treatment 2014-2016 - Trends and Figures', providing the latest available data regarding fertility treatments in the UK
19 March 2018 - by Jen Willows 
A second US fertility clinic has reported a malfunction of a tank used to store frozen eggs and embryos...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.